A phase 3 study of the efficacy, safety, and pharmacokinetics profile of subcutaneous vs intravenous nivolumab + relatlimab fixed-dose combination in previously untreated metastatic or unresectable melanoma (RELATIVITY-127)

Saved in:

Bibliographic Details
Main Authors:	G.V. Long, R. Gutzmer, A. Haydon, E. Muñoz Couselo, C. Lebbé, M. Carlino, W. Chow, F. Couture, P. Lau, F. Spagnolo, A.J. Alves Wainstein, D. Palmieri, C. Rojas García, G. de Velasco Oria de Rueda, I. Mehmi, D. Patel, A. Shaikh, N.R. Chowdhury, S. Bathena, S. Suryawanshi, P. Rutkowski
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	EJC Skin Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772611824001319
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative safety of nivolumab plus ipilimumab versus nivolumab plus relatlimab in advanced melanoma: a pharmacovigilance study based on the FDA adverse event reporting system (FAERS)
by: Shanshan Xu, et al.
Published: (2025-07-01)

Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020
by: James Larkin, et al.
Published: (2025-02-01)

A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome
by: Ian M. Bouligny, et al.
Published: (2025-02-01)

Exceptional Response of Therapy-Resistant SF3B1 Mutant Conjunctival Melanoma to Nivolumab/LAG3 Inhibitor Relatlimab Combination Therapy: A Case Report
by: Fernando M. Nuñez, et al.
Published: (2025-02-01)

127 Stroke Prevention in Atrial Fibrillation/Flutter Targeting the uNTreated (SPAFF-TNT) at the Orlando Veteran Affairs (VA) Healthcare System
by: Natalie R. Ciccone, et al.
Published: (2025-05-01)

Sensation™ Brand ‘Florida127’ Strawberry
by: Vance M. Whitaker, et al.
Published: (2014-10-01)

Sensation™ Brand ‘Florida127’ Strawberry
by: Vance M. Whitaker, et al.
Published: (2014-10-01)

HOLOPROSENCEPHALY: CHROMOSOMAL ABNORMALITIES IN THE ETIOPATHOGENESIS OF 127 ANTENATAL CASES
by: Birsen Karaman, et al.
Published: (2021-04-01)

Nivolumab in real-life clinical practice
by: M. A. Lyadova, et al.
Published: (2019-12-01)

Consumerism and Conflict: Case Study of NCT 127 Fans on Twitter
by: Videlia Suryaning Triasyoga, et al.
Published: (2024-10-01)

127. Gender-Affirming Sigmoid Colon Vaginoplasty: Does BMI Impact Outcomes?
by: Isabel A. Snee, BS, et al.
Published: (2025-05-01)

Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice
by: Nawaf A. Aloufi, et al.
Published: (2021-12-01)

Antiphospholipid Antibody Induced by Nivolumab
by: Ahmed Aburahma, et al.
Published: (2018-01-01)

Nivolumab induced myxedema crisis
by: Uqba Khan, et al.
Published: (2017-08-01)

Nivolumab Induced Palmoplantar Keratoderma
by: Singamsetty Sushma, et al.
Published: (2025-07-01)

Obesity in Children Untreated for ADHD
by: J Gordon Millichap
Published: (2008-08-01)

Combined Use of Cabozantinib and Nivolumab in Clinical Practice
by: V. E. Askarov, et al.
Published: (2024-04-01)

Novel TMEM127 Variant Associated to Bilateral Phaeochromocytoma with an Uncommon Clinical Presentation
by: Antía Fernández-Pombo, et al.
Published: (2019-01-01)

Abstract 127: Delayed Thrombectomy In A Patient With Recurrent MCA Strokes
by: Pradeep Joseph, et al.
Published: (2023-11-01)

Año XXXIII (1987): núm. 127, 128, 129 y 130
by: Sin Autor
Published: (2015-05-01)

Decreased CD127 Expression on CD4+ T-Cells and Elevated Frequencies of CD4+CD25+CD127− T-Cells in Children with Long-Lasting Type 1 Diabetes
by: Marcin Moniuszko, et al.
Published: (2013-01-01)

Escherichia coli O127 group 4 capsule proteins assemble at the outer membrane.
by: Matthew R Larson, et al.
Published: (2021-01-01)

Metastatic Merkel cell carcinoma response to nivolumab
by: Leslie A. Fecher, et al.
Published: (2016-11-01)

Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
by: Dirk Schadendorf, et al.
Published: (2024-03-01)

First-line Nivolumab plus Ipilimumab in patients with advanced melanoma previously treated with adjuvant systemic therapy
by: K. Kisielewska, et al.
Published: (2024-01-01)

Preclinical comparison of prolgolimab, pembrolizumab and nivolumab
by: Aleksandr Gordeev, et al.
Published: (2024-10-01)

Membranoproliferative Glomerulonephritis Associated with Nivolumab Therapy
by: Jessica Cruz-Whitley, et al.
Published: (2020-01-01)

Neuropsychiatric Features of Untreated Secondary Hypothyroidism
by: Gregory Everett, et al.
Published: (2024-11-01)

Antileukemic Activity of 1-Oxyphenazine Produced by Pseudomonas Aureofaciens Phz 127/11
by: I. N. FEKLISTOVA, et al.
Published: (2014-07-01)

Antileukemic Activity of 1-Oxyphenazine Produced by Pseudomonas Aureofaciens Phz 127/11
by: I. N. FEKLISTOVA, et al.
Published: (2016-07-01)

Versatile use of dermal substitutes: A retrospective survey of 127 consecutive cases
by: Giovanni Nicoletti, et al.
Published: (2018-01-01)

Genetic Analysis of EGLN1 C127S Variant in Taiwanese Parkinson’s Disease
by: Han-Lin Chiang, et al.
Published: (2020-01-01)

Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
by: Leslie A. Fecher, et al.
Published: (2017-08-01)

Erratum: “Spectral Variations across Latitudes on Asteroid (3200) Phaethon” (2025, ApJ, 980, 127)
by: M. Angrisani, et al.
Published: (2025-01-01)

Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
by: S. Dalle, et al.
Published: (2024-01-01)

Commentary: Not every untreated acute type A dissection will rupture, but every untreated malperfusion will result in deathCentral Message
by: Bo Yang, MD, PhD
Published: (2020-12-01)

Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
by: Robert G Maki, et al.
Published: (2025-06-01)

D127. Hand Infection Encounters in the Emergency Department in the Presence of Concomitant Psychiatric Diagnoses
by: Shelley R. Edwards, BS, et al.
Published: (2025-05-01)

Temperature Sensitive Pluronic F127‐Based Gels Incorporating Natural Therapeutic Agents
by: Alexandra Lupu, et al.
Published: (2025-04-01)

Dziedziczenie beztestamentowe krewnych kognacyjnych w świetle nowel 118 i 127 Justyniana
by: Agnieszka Stęplowska
Published: (2002-06-01)